1. |
Shekar K, Grewal J, Lisa Sutt A, et al. Individualizing sedation in acute respiratory distress syndrome patients on extracorporeal membrane oxygenation. ASAIO J, 2019, 65(4): e44-e45.
|
2. |
Lal A, Nabzdyk C, Ramakrishna H, et al. Consider heightened awareness of propofol infusion syndrome after extracorporeal membrane oxygenation (ECMO) decannulation. J Cardiothorac Vasc Anesth, 2020, 34(8): 2174-2177.
|
3. |
Jackson DL, Proudfoot CW, Cann KF, et al. A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care, 2010, 14(2): R59.
|
4. |
deBacker J, Tamberg E, Munshi L, et al. Sedation practice in extracorporeal membrane oxygenation-treated patients with acute respiratory distress syndrome: a retrospective study. ASAIO J, 2018, 64(4): 544-551.
|
5. |
Shehabi Y, Bellomo R, Reade M, et al. Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med, 2012, 186(8): 724-731.
|
6. |
Balzer F, Weiß B, Kumpf O, et al. Early deep sedation is associated with decreased in-hospital and two-year follow-up survival. Crit Care, 2015, 19(1): 197.
|
7. |
DeGrado JR, Hohlfelder B, Ritchie BM, et al. Evaluation of sedatives, analgesics, and neuromuscular blocking agents in adults receiving extracorporeal membrane oxygenation. J Crit Care, 2017, 37: 1-6.
|
8. |
Shekar K, Roberts JA, Mcdonald CI, et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Crit Care, 2015, 19(1): 164.
|
9. |
Hammarén E, Rosenberg PH, Hynynen M. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro. Br J Anaesth, 1999, 82(1): 38-40.
|
10. |
Shekar K, Roberts JA, Mullany DV, et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure. Anaesth Intensive Care, 2012, 40(4): 648-655.
|
11. |
Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis, 2020, 94: 55-58.
|
12. |
Fisser C, Lüdtke P, Lubnow M, et al. Effect of tracheotomy on sedation, ventilation and ECMO adjustments in patients with acute respiratory failure on venovenous ECMO: a 10-year analysis. (2019-09-28) [2020-06-10]. https://www.researchgate.net/publication/337589127_Effect_of_tracheotomy_on_sedation_ventilation_and_ECMO_adjustments_in_patients_with_acute_respiratory_failure_on_venovenous_ECMO_a_10-year_analysis.
|
13. |
Dzierba AL, Abrams D, Madahar P, et al. Current practice and perceptions regarding pain, agitation and delirium management in patients receiving venovenous extracorporeal membrane oxygenation. J Crit Care, 2019, 53: 98-106.
|
14. |
DAS-Taskforce 2015, Baron R, Binder A, et al. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015)-short version. Ger Med Sci, 2015, 13: doc19.
|
15. |
Celis-Rodríguez E, Birchenall C, de la Cal MÁ, et al. Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients. Med Intensiva, 2013, 37(8): 519-574.
|
16. |
Meiser A, Bomberg H, Lepper PM, et al. Inhaled sedation in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation. Anesth Analg, 2017, 125(4): 1235-1239.
|
17. |
Shekar K, Roberts JA, Ghassabian S, et al. Sedation during extracorporeal membrane oxygenation-why more is less. Anaesth Intensive Care, 2012, 40(6): 1067-1069.
|